Skip to main content
Steven Sloan, MD, Pathology, Boston, MA

StevenRSloanMD

Pathology Boston, MA

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Blood Bank Medical Director at Boston Children's Hospital

Dr. Sloan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sloan's full profile

Already have an account?

  • Office

    300 Longwood Ave
    Bader 4
    Boston, MA 02115
    Phone+1 617-355-6268

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 1994 - 1996
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1990 - 1994
  • New York University School of Medicine
    New York University School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - Present
  • MA State Medical License
    MA State Medical License 2000 - 2022
  • PA State Medical License
    PA State Medical License 1993 - 1996
  • American Board of Pathology Clinical Pathology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Assessment of the Plasmic Score Utility for Classification of Pediatric Thrombotic Microangiopathies
    Steven Richard Sloan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • By Steven L Spitalnik Md Clinical Pathology Board Review 1e 1 Harpsc Paperback
    By Steven L Spitalnik Md Clinical Pathology Board Review 1e 1 Harpsc PaperbackJune 27th, 2020
  • Targeted Genomic CRISPR-Cas9 Screen Identifies MAP4K4 as Essential for Glioblastoma Invasion
    Targeted Genomic CRISPR-Cas9 Screen Identifies MAP4K4 as Essential for Glioblastoma InvasionSeptember 30th, 2019